Medications

Supermaterial gives rejected drugs a new chance

More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. Now Uppsala University researchers show that the new material Upsalite, ...

Alzheimer's disease & dementia

Researchers identify urgent need for Alzheimer's drug development

Researchers at the Cleveland Clinic Lou Ruvo Center for Brain Health have conducted the first-ever analysis of clinical trials for Alzheimer's disease (AD), revealing an urgent need to increase the number of agents entering ...

Oncology & Cancer

Promising results for Swedish cancer drug candidate

A new study conducted by scientists from the Dana-Farber Cancer Institute at Harvard Medical School and Karolinska Institutet in Sweden presents very promising results for the treatment of the cancer form multiple myeloma. ...

Oncology & Cancer

Digging deeper into cancer

What a pathologist looks for in a Pap test sample, but hopes not to find, are oddly shaped cells with abnormally large nuclei. The same is true for prostate and lung cancer biopsies. In fact, most cancer cells display distorted ...

Medications

Mapping mechanisms to medications

By charting shifts in gene expression, researchers can gain deeper insights into drug mechanisms and side effects.

page 12 from 20